Patents by Inventor Penchala Narasimharao Meka

Penchala Narasimharao Meka has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12209097
    Abstract: Described herein are compounds of the formula (I), as well as pharmaceutical compositions comprising such compounds, and methods for using such compounds/pharmaceutical compositions for treating neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, Huntington's disease, and multiple sclerosis (MS).
    Type: Grant
    Filed: October 24, 2022
    Date of Patent: January 28, 2025
    Assignee: University of Massachusetts
    Inventors: Jeanne A. Hardy, Penchala Narasimharao Meka
  • Publication number: 20230121110
    Abstract: Described herein are compounds of the formula (I), as well as pharmaceutical compositions comprising such compounds, and methods for using such compounds/pharmaceutical compositions for treating neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, Huntington's disease, and multiple sclerosis (MS).
    Type: Application
    Filed: October 24, 2022
    Publication date: April 20, 2023
    Inventors: Jeanne A. Hardy, Penchala Narasimharao Meka
  • Patent number: 11512094
    Abstract: Described herein are compounds of the formula (I), as well as pharmaceutical compositions comprising such compounds, and methods for using such compounds/pharmaceutical compositions for treating neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, Huntington's disease, and multiple sclerosis (MS).
    Type: Grant
    Filed: January 11, 2019
    Date of Patent: November 29, 2022
    Assignee: University of Massachusetts
    Inventors: Jeanne A. Hardy, Penchala Narasimharao Meka
  • Publication number: 20200339596
    Abstract: Described herein are compounds of the formula (I), as well as pharmaceutical compositions comprising such compounds, and methods for using such compounds/pharmaceutical compositions for treating neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, Huntington's disease, and multiple sclerosis (MS).
    Type: Application
    Filed: January 11, 2019
    Publication date: October 29, 2020
    Inventors: Jeanne A. Hardy, Penchala Narasimharao Meka